All News
Phys.org / Cataract surgery will be needed in space, surgeon predicts
An eye surgeon with a passion for space since childhood predicts that as astronauts start to make journeys to the moon and Mars in the near future, eye surgery in space will eventually become a necessity.
Medical Xpress / Training nurses like athletes
Chandler Browning always dreamed of being part of The University of Texas at Arlington's nationally recognized nursing program and pursuing her goal of becoming a certified registered nurse anesthetist. Now in her first semester ...
Medical Xpress / Ivonescimab significantly improves overall survival versus pembrolizumab in advanced lung cancer
Ivonescimab significantly prolonged overall survival compared with pembrolizumab as first-line treatment for patients with PD-L1-positive advanced non-small cell lung cancer (NSCLC), according to a prespecified interim analysis ...
Medical Xpress / Trial supports MRI surveillance over preventive brain radiation in small-cell lung cancer
Results from the international phase 3 SWOG S1827 MAVERICK trial show that brain MRI surveillance alone improved cognitive failure-free survival compared with MRI surveillance plus prophylactic cranial irradiation (PCI) in ...
Phys.org / AI could make holiday planning easier for overwhelmed travelers
Generative AI could help overwhelmed travelers organize their thoughts, compare options and complete vacation plans they might otherwise abandon, according to new research from the University of Surrey.
Medical Xpress / Combination therapy does not meet primary endpoints in first-line PD-L1-high metastatic non-small cell lung cancer
Sacituzumab govitecan (SG) plus pembrolizumab did not demonstrate a statistically significant improvement in progression-free survival compared with pembrolizumab alone as first-line treatment for patients with metastatic ...
Medical Xpress / Trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer
Results from the randomized Phase III ARTEMIS-008 trial show that risvutatug rezetecan (Ris-Rez), a B7-H3-directed antibody-drug conjugate, significantly improved overall survival compared with topotecan in patients with ...
Phys.org / Magnetic nanoparticles detect amoxicillin allergy with 98% sensitivity in early tests
A multidisciplinary scientific team at the University of Malaga has developed a new technology based on magnetic nanoparticles that enables precise, rapid and reliable diagnosis of allergy to beta-lactam antibiotics, including ...
Phys.org / Six ways people have used magic to protect their homes throughout history—from witch bottles to 'hag stones'
Virtually all cultures and eras fizz with magic. You might call it a secret ingredient of human life because magic takes so many forms and serves so many functions.
Medical Xpress / Tam-Peli extends survival by nearly four months in relapsed small-cell lung cancer
The phase 3 TAISHAN-302 trial found that tambotatug pelitecan (Tam-Peli, YL201), a novel anti-B7-H3 antibody-drug conjugate, significantly improved overall survival, progression-free survival and objective response rate compared ...
Medical Xpress / Simple perception test can accurately predict success of laser surgery for age-related vision loss
Laser blended vision is a treatment for presbyopia, the natural deterioration of our ability to see things close up that develops in people 40 and older. This type of laser surgery aims to correct one eye for seeing clearly ...
Tech Xplore / Altman tells Fortune OpenAI will not go public in 2026
OpenAI will not go public this year, the company's chief executive, Sam Altman, said in an interview released Saturday, citing safety concerns over artificial intelligence.
